Serum and dietary magnesium and the risk for type 2 diabetes mellitus -: The atherosclerosis risk in communities study

被引:340
作者
Kao, WHL
Folsom, AR
Nieto, FJ
Mo, JP
Watson, RL
Brancati, FL
机构
[1] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA
[4] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
[5] Univ Mississippi, Med Ctr, Div Epidemiol, Jackson, MS 39216 USA
关键词
D O I
10.1001/archinte.159.18.2151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Experimental studies in animals and cross-sectional studies in humans have suggested that low serum magnesium levels might lead to type 2 diabetes; however, this association has not been examined prospectively. Methods: We assessed the risk for type 2 diabetes associated with low serum magnesium level and low dietary magnesium intake in a cohort of nondiabetic middle-aged adults (N = 12128) from the Atherosclerosis Risk in Communities Study during 6 years of follow-up. Fasting serum magnesium level, categorized into 6 levels, and dietary magnesium intake, categorized into quartiles, were measured at the baseline examination. Incident type 2 diabetes was defined by self-report of physician diagnosis, use of diabetic medication, fasting glucose level of at least 7.0 mmol/L (126 mg/dL), or nonfasting glucose level of at least 11.1 mmol/L (200 mg/dL). Results: Among white participants, a graded inverse relationship between serum magnesium levels and incident type 2 diabetes was observed. From the highest to the lowest serum magnesium levels, there was an approximate 2-fold increase in incidence rate (11.1, 12.2, 13.6, 12.8, 15.8, and 22.8 per 1000 person-years; P = .001). This graded association remained significant after simultaneous adjustment for potential confounders, including diuretic use. Compared with individuals with serum magnesium levels of 0.95 mmol/L (1.90 mEq/L) or greater, the adjusted relative odds of incident type 2 diabetes rose progressively across the following lower magnesium categories: 1.13 (95% CI, 0.79-1.61), 1.20 (95% CI, 0.86-1.68), 1.11 (95% CI, 0.80-1.56), 1.24 (95% CI, 0.86-1.78), and 1.76 (95% CI, 1.18-2.61) (for trend, P = .01) In contrast, little or no association was observed in black participants. No association was detected between dietary magnesium intake and the risk for incident type 2 diabetes in black or white participants. Conclusions: Among white participants, low serum magnesium level is a strong, independent predictor of incident type 2 diabetes. That low dietary magnesium intake does not confer risk for type 2 diabetes implies that compartmentalization and renal handling of magnesium may be important in the relationship between low serum magnesium levels and the risk for type 2 diabetes.
引用
收藏
页码:2151 / 2159
页数:9
相关论文
共 52 条
[1]   EFFECTS OF INSULIN ON PLASMA MAGNESIUM IN NONINSULIN-DEPENDENT DIABETES-MELLITUS - EVIDENCE FOR INSULIN-RESISTANCE [J].
ALZAID, AA ;
DINNEEN, SF ;
MOYER, TP ;
RIZZA, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04) :1376-1381
[2]  
*AM DIAB ASS, 1997, DANG TOLL DIAB AM DI
[3]  
BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
[4]   MAGNESIUM SUPPLEMENTATION REDUCES DEVELOPMENT OF DIABETES IN A RAT MODEL OF SPONTANEOUS NIDDM [J].
BALON, TW ;
GU, JL ;
TOKUYAMA, Y ;
JASMAN, AP ;
NADLER, JL .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 269 (04) :E745-E752
[5]   CELLULAR IONIC EFFECTS OF INSULIN IN NORMAL HUMAN ERYTHROCYTES - A NUCLEAR-MAGNETIC-RESONANCE STUDY [J].
BARBAGALLO, M ;
GUPTA, RK ;
RESNICK, LM .
DIABETOLOGIA, 1993, 36 (02) :146-149
[6]   LIVER GLUCOKINASE - DECREASED ACTIVITY IN PATIENTS WITH TYPE-II DIABETES [J].
CARO, JF ;
TRIESTER, S ;
PATEL, VK ;
TAPSCOTT, EB ;
FRAZIER, NL ;
DOHM, GL .
HORMONE AND METABOLIC RESEARCH, 1995, 27 (01) :19-22
[7]  
*CDCP, 1976, PUBLICATION CDC
[8]   DIET AND RISK OF CLINICAL DIABETES IN WOMEN [J].
COLDITZ, GA ;
MANSON, JE ;
STAMPFER, MJ ;
ROSNER, B ;
WILLETT, WC ;
SPEIZER, FE .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1992, 55 (05) :1018-1023
[9]  
CONNERTY HV, 1966, AM J CLIN PATHOL, V45, P290
[10]   PATHOGENESIS OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS - A BALANCED OVERVIEW [J].
DEFRONZO, RA .
DIABETOLOGIA, 1992, 35 (04) :389-397